Recursion Pharmaceuticals, Inc. logo

Recursion Pharmaceuticals, Inc.

NASDAQ:RXRX

Overview | Financials
Company Name Recursion Pharmaceuticals, Inc.
Symbol RXRX
Currency USD
Price 6.64
Market Cap 1,887,028,240
Dividend Yield 0%
52-week-range 5.035 - 15.74
Industry Biotechnology
Sector Healthcare
CEO Dr. Christopher C. Gibson Ph.D.
Website https://www.recursion.com

An error occurred while fetching data.

About Recursion Pharmaceuticals, Inc.

Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cavernous malformation; REC-2282 for the treatment

Related Stocks

Simulations Plus, Inc. logo

Simulations Plus, Inc.

SLP

27.49 USD

SNDL Inc. logo

SNDL Inc.

SNDL

2.16 USD

Ventyx Biosciences, Inc. logo

Ventyx Biosciences, Inc.

VTYX

2.15 USD

BridgeBio Pharma, Inc. logo

BridgeBio Pharma, Inc.

BBIO

25.2 USD

Varex Imaging Corporation logo

Varex Imaging Corporation

VREX

13.25 USD

Financials

Numbers are in millions USD

Numbers are in millions USD